Comprehensive description of blood microbiome from healthy donors assessed by 16S targeted metagenomic sequencing

Transfusion

Volumn 56, Issue 5, 2016, Pages 1138-1147

  Païssé, Sandrine ^a   Valle, Carine ^a   Servant, Florence ^a   Courtney, Michael ^a   Burcelin, Rémy ^a,b   Amar, Jacques ^a,c   Lelouvier, Benjamin ^a  

^a VAIOMER SAS   (France)

^b University Hospital of Toulouse   (France)

^c CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; DNA 16S; RIBOSOME DNA;

ACTINOBACTERIA; ADULT; ARTICLE; BACTEROIDETES; BLOOD BUFFY COAT; BLOOD DONOR; BLOOD MICROFLORA; BLOOD SAMPLING; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; FIRMICUTES; GENE SEQUENCE; GENE TARGETING; HUMAN; MALE; METAGENOMICS; MICROBIOME; NONHUMAN; NORMAL HUMAN; PHYLUM; POLYMERASE CHAIN REACTION; PROTEOBACTERIA; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; ADOLESCENT; AGED; BLOOD; BLOOD SAFETY; FRANCE; HEALTH SURVEY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; PHYLOGENY; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLOOD; BLOOD DONORS; BLOOD SAFETY; DNA, BACTERIAL; DNA, RIBOSOMAL; FRANCE; HEALTHY VOLUNTEERS; HUMANS; METAGENOMICS; MICROBIOTA; MIDDLE AGED; PHYLOGENY; PUBLIC HEALTH SURVEILLANCE; YOUNG ADULT;

EID: 84958211659     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13477     Document Type: Article

References (60)

1. Potgieter M, Bester J, Kell DB, et al., The dormant blood microbiome in chronic, inflammatory diseases. FEMS Microbiol Rev 2015; 39: 567-91.
2. Damgaard C, Magnussen K, Enevold C, et al., Viable bacteria associated with red blood cells and plasma in freshly drawn blood donations. PLoS One 2015; 10: e0120826.
3. McLaughlin RW, Vali H, Lau PC, et al., Are there naturally occurring pleomorphic bacteria in the blood of healthy humans? J Clin Microbiol 2002; 40: 4771-5.
4. Nikkari S, McLaughlin IJ, Bi W, et al., Does blood of healthy subjects contain bacterial ribosomal DNA? J Clin Microbiol 2001; 39: 1956-9.
5. Manzo VE, Bhatt AS., The human microbiome in hematopoiesis and hematologic disorders. Blood 2015; 126: 311-8.
6. Amar J, Lange C, Payros G, et al., Blood microbiota dysbiosis is associated with the onset of cardiovascular events in a large general population: the D.E.S.I.R. study. PLoS One 2013; 8: e54461.
7. Cani PD, Amar J, Iglesias MA, et al., Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56: 1761-72.
8. Amar J, Chabo C, Waget A, et al., Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med 2011; 3: 559-72.
9. Wang Y, Kasper LH., The role of microbiome in central nervous system disorders. Brain Behav Immun 2014; 38: 1-12.
10. Qin N, Yang F, Li A, et al., Alterations of the human gut microbiome in liver cirrhosis. Nature 2014; 513: 59-64.
11. Chen P, Schnabl B., Host-microbiome interactions in alcoholic liver disease. Gut Liver 2014; 8: 237-41.
12. Garrett WS., Cancer and the microbiota. Science 2015; 348: 80-6.
13. Itzhaki RF, Wozniak MA, Appelt DM, et al., Infiltration of the brain by pathogens causes Alzheimer's disease. Neurobiol Aging 2004; 25: 619-27.
14. Friedland RP., Mechanisms of molecular mimicry involving the microbiota in neurodegeneration. J Alzheimers Dis 2015; 45: 349-62.
15. Catanzaro R, Anzalone M, Calabrese F, et al., The gut microbiota and its correlations with the central nervous system disorders. Panminerva Med 2015; 57: 127-43.
16. Blajchman MA, Goldman M, Baeza F., Improving the bacteriological safety of platelet transfusions. Transfus Med Rev 2004; 18: 11-24.
17. Brecher ME, Hay SN., Bacterial contamination of blood components. Clin Microbiol Rev 2005; 18: 195-204.
18. Lafeuillade B, Eb F, Ounnoughene N, et al., Residual risk and retrospective analysis of transfusion-transmitted bacterial infection reported by the French National Hemovigilance Network from 2000 to 2008. Transfusion 2015; 55: 636-46.
19. Snyder EL, Stramer SL, Benjamin RJ., The safety of the blood supply- time to raise the bar. N Engl J Med 2015; 372: 1882-5.
20. Gosiewski T, Flis A, Sroka A, et al., Comparison of nested, multiplex, qPCR; FISH; SeptiFast and blood culture methods in detection and identification of bacteria and fungi in blood of patients with sepsis. BMC Microbiol 2014; 14:313.
21. Grif K, Fille M, Würzner R, et al., Rapid detection of bloodstream pathogens by real-time PCR in patients with sepsis. Wien Klin Wochenschr 2012; 124: 266-70.
22. Riedel S, Carroll KC., Laboratory detection of sepsis: biomarkers and molecular approaches. Clin Lab Med 2013; 33: 413-37.
23. Naccache SN, Federman S, Veeraraghavan N, et al., A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples. Genome Res 2014; 24: 1180-92.
24. Tichopad A, Didier A, Pfaffl MW., Inhibition of real-time RT-PCR quantification due to tissue-specific contaminants. Mol Cell Probes 2004; 18: 45-50.
25. Salter SJ, Cox MJ, Turek EM, et al., Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol 2014; 12: 87.
26. Laurence M, Hatzis C, Brash DE., Common contaminants in next-generation sequencing that hinder discovery of low-abundance microbes. PLoS One 2014; 9: e97876.
27. Nadkarni MA, Martin FE, Jacques NA, et al., Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 2002; 148: 257-66.
28. Lluch J, Servant F, Païssé S, et al., The characterization of novel tissue microbiota using an optimized 16S metagenomic sequencing pipeline. PLoS One 2015; 10: e0142334.
29. Camacho C, Coulouris G, Avagyan V, et al., BLAST+: architecture and applications. BMC Bioinformatics 2009; 10: 421.
30. Segata N, Izard J, Waldron L, et al., Metagenomic biomarker discovery and explanation. Genome Biol 2011; 12: R60.
31. Ward DM, Cohan FM, Bhaya D, et al., Genomics, environmental genomics and the issue of microbial species. Heredity (Edinb) 2008; 100: 207-19.
32. Janda JM, Abbott SS., 16S rRNA gene sequencing for bacterial identification in the diagnostic laboratory: pluses, perils, and pitfalls. J Clin Microbiol 2007; 45: 2761-4.
33. Goodrich JK, Di Rienzi SC, Poole AC, et al., Conducting a microbiome study. Cell 2014; 158: 250-62.
34. Peleg AY, Seifert H, Paterson DL., Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21: 538-82.
35. Garazi M, Singer C, Tai J, et al., Bloodstream infections caused by Stenotrophomonas maltophilia: a seven-year review. J Hosp Infect 2012; 81: 114-8.
36. Allen SJ., Gastrointestinal complications and cardiac surgery. J Extra Corpor Technol 2014; 46: 142-9.
37. Ramirez P, Gordón M, Cortes C, et al., Blood culture contamination rate in an intensive care setting: effectiveness of an education-based intervention. Am J Infect Control 2015; 43: 844-7.
38. Dawson S., Blood culture contaminants. J Hosp Infect 2014; 87: 1-10.
39. Větrovský T, Baldrian P., The variability of the 16S rRNA gene in bacterial genomes and its consequences for bacterial community analyses. PLoS One 2013; 8: e57923.
40. Epstein SS., The phenomenon of microbial uncultivability. Curr Opin Microbiol 2013; 16: 636-42.
41. Tanaka T, Kawasaki K, Daimon S, et al., A hidden pitfall in the preparation of agar media undermines microorganism cultivability. Appl Environ Microbiol 2014; 80: 7659-66.
42. Kirn TJ, Weinstein MP., Update on blood cultures: how to obtain, process, report, and interpret. Clin Microbiol Infect 2013; 19: 513-20.
43. Kaprelyants AS, Gottschal JC, Kell DB., Dormancy in non-sporulating bacteria. FEMS Microbiol Rev 1993; 10: 271-85.
44. Kell DB, Kaprelyants AS, Weichart DH, et al., Viability and activity in readily culturable bacteria: a review and discussion of the practical issues. Antonie Van Leeuwenhoek 1998; 73: 169-87.
45. Pohlod DJ, Mattman LH, Tunstall L., Structures suggesting cell-wall-deficient forms detected in circulating erythrocytes by fluorochrome staining. Appl Microbiol 1972; 23: 262-7.
46. Almenoff PL, Johnson A, Lesser M, et al., Growth of acid fast L forms from the blood of patients with sarcoidosis. Thorax 1996; 51: 530-3.
47. Mercier R, Kawai Y, Errington J., General principles for the formation and proliferation of a wall-free (L-form) state in bacteria. Elife 2014; 3. doi: 10.7554/eLife.04629.
48. Turnbaugh PJ, Ley RE, Mahowald MA, et al., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-31.
49. Wang L, Llorente C, Hartmann P, et al., Methods to determine intestinal permeability and bacterial translocation during liver disease. J Immunol Methods 2015; 421: 44-53.
50. Ono S, Tsujimoto H, Yamauchi A, et al., Detection of microbial DNA in the blood of surgical patients for diagnosing bacterial translocation. World J Surg 2005; 29: 535-9.
51. Bellot P, García-Pagán JC, Francés R, et al., Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis. Hepatology 2010; 52: 2044-52.
52. Costello EK, Lauber CL, Hamady M, et al., Bacterial community variation in human body habitats across space and time. Science 2009; 326: 1694-7.
53. Blumberg N, Zhao H, Wang H, et al., The intention-to-treat principle in clinical trials and meta-analyses of leukoreduced blood transfusions in surgical patients. Transfusion 2007; 47: 573-81.
54. Phelan HA, Sperry JL, Friese RS., Leukoreduction before red blood cell transfusion has no impact on mortality in trauma patients. J Surg Res 2007; 138: 32-6.
55. Wang Z, Zhang L, Guo Z, et al., A unique feature of iron loss via close adhesion of Helicobacter pylori to host erythrocytes. PLoS One 2012; 7: e50314.
56. Horzempa J, O'Dee DM, Stolz DB, et al., Invasion of erythrocytes by Francisella tularensis. J Infect Dis 2011; 204: 51-9.
57. Brekke OL, Hellerud BC, Christiansen D, et al., Neisseria meningitidis and Escherichia coli are protected from leukocyte phagocytosis by binding to erythrocyte complement receptor 1 in human blood. Mol Immunol 2011; 48: 2159-69.
58. Yamaguchi M, Terao Y, Mori-Yamaguchi Y, et al., Streptococcus pneumoniae invades erythrocytes and utilizes them to evade human innate immunity. PLoS One 2013; 8: e77282.
59. Minasyan H., Erythrocyte and blood antibacterial defense. Eur J Microbiol Immunol 2014; 4: 138-43.
60. Minasyan HA., Erythrocyte and leukocyte: two partners in bacteria killing. Int Rev Immunol 2014; 33: 490-7.